AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
Log in

NYSE:METMetlife Stock Price, Forecast & News

$36.02
-1.07 (-2.88 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$35.92
Now: $36.02
$36.88
50-Day Range
$32.39
MA: $36.57
$43.00
52-Week Range
$22.85
Now: $36.02
$53.28
Volume5.14 million shs
Average Volume7.33 million shs
Market Capitalization$32.69 billion
P/E Ratio3.83
Dividend Yield4.96%
Beta1.34
MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
Read More
Metlife logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 3.0Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.59 out of 5 stars


Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$69.62 billion
Cash Flow$5.93 per share
Book Value$72.18 per share

Profitability

Net Income$5.90 billion

Miscellaneous

Employees49,000
Market Cap$32.69 billion
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Metlife (NYSE:MET) Frequently Asked Questions

How has Metlife's stock been impacted by COVID-19 (Coronavirus)?

Metlife's stock was trading at $33.30 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MET stock has increased by 8.2% and is now trading at $36.02. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Metlife?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Metlife.

When is Metlife's next earnings date?

Metlife is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Metlife.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) posted its quarterly earnings data on Wednesday, May, 6th. The financial services provider reported $1.58 EPS for the quarter, topping the consensus estimate of $1.44 by $0.14. The financial services provider earned $15.54 billion during the quarter, compared to the consensus estimate of $16.38 billion. Metlife had a net margin of 12.37% and a return on equity of 8.85%. The company's revenue was up .6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.48 earnings per share. View Metlife's earnings history.

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Tuesday, April 28th. Stockholders of record on Friday, May 8th will be given a dividend of $0.46 per share on Friday, June 12th. This represents a $1.84 annualized dividend and a dividend yield of 5.11%. The ex-dividend date of this dividend is Thursday, May 7th. This is an increase from Metlife's previous quarterly dividend of $0.44. View Metlife's dividend history.

How will Metlife's stock buyback program work?

Metlife announced that its Board of Directors has initiated a stock repurchase plan on Thursday, November 1st 2018, which permits the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 4.6% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's management believes its shares are undervalued.

What price target have analysts set for MET?

9 brokerages have issued 1-year price objectives for Metlife's stock. Their forecasts range from $32.00 to $47.00. On average, they anticipate Metlife's share price to reach $41.43 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price. View analysts' price targets for Metlife.

Has Metlife been receiving favorable news coverage?

News articles about MET stock have trended negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Metlife earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Metlife.

Are investors shorting Metlife?

Metlife saw a decline in short interest in June. As of June 15th, there was short interest totaling 16,880,000 shares, a decline of 6.9% from the May 31st total of 18,140,000 shares. Based on an average trading volume of 8,070,000 shares, the short-interest ratio is currently 2.1 days. Currently, 2.2% of the shares of the company are short sold. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

What other stocks do shareholders of Metlife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include AT&T (T), General Electric (GE), Walt Disney (DIS), Verizon Communications (VZ), IBM (IBM), Pfizer (PFE), Exxon Mobil (XOM), Bank of America (BAC), Johnson & Johnson (JNJ) and Intel (INTC).

Who are Metlife's key executives?

Metlife's management team includes the following people:
  • Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
  • Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
  • Mr. John Arthur Hall, Sr. VP & Head of Investor Relations

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Who are Metlife's major shareholders?

Metlife's stock is owned by a number of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.02%), Cullinan Associates Inc. (0.01%), Farmers Trust Co. (0.01%), Municipal Employees Retirement System of Michigan (0.01%), Everence Capital Management Inc. (0.00%) and Burns J W & Co. Inc. NY (0.00%). Company insiders that own Metlife stock include Carlos M Gutierrez, John D Mccallion, Steven A Kandarian and Steven J Goulart. View institutional ownership trends for Metlife.

Which institutional investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Diversified Trust Co, Everence Capital Management Inc., Cullinan Associates Inc., Wiley BROS. Aintree Capital LLC, and Burns J W & Co. Inc. NY. View insider buying and selling activity for Metlife.

Which institutional investors are buying Metlife stock?

MET stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Park National Corp OH, Farmers Trust Co., Municipal Employees Retirement System of Michigan, Ellevest Inc., TRUE Private Wealth Advisors, and Pinnacle Bank. View insider buying and selling activity for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $36.02.

How big of a company is Metlife?

Metlife has a market capitalization of $32.69 billion and generates $69.62 billion in revenue each year. The financial services provider earns $5.90 billion in net income (profit) each year or $6.11 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

What is Metlife's official website?

The official website for Metlife is www.metlife.com.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.